Anshul Bhalla is a Nephrology physician. OpenAlex indexes 54 publications with 2,019 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1265 Union Ave
4 Shorb Tower
Memphis, TN 381043415
Telephone
901-478-9183Provider last certified this registry record 16 Jan 2024.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20221 payment
- SANOFI-AVENTIS U.S. LLCProgram year20221 payment
- Novo Nordisk IncProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
40.8%Corticosteroid26.9%Prednisone100%Part D≥133 patientsDPP-4 inhibitor7%Tradjenta76%Januvia24%Part D<11 patients+ 2 more classes in this area
Cardiovascular
28.2%Statin8.1%Atorvastatin Calcium75%Pravastatin Sodium16%Rosuvastatin Calcium10%Part D<11 patientsCalcium channel blocker6.4%Amlodipine Besylate100%Part D≥34 patients+ 5 more classes in this area
Anti-infectives
14.4%Short-acting sulfonamides6.5%Sulfamethoxazole-Trimethoprim100%Part D≥31 patientsAzole Antifungal3.7%Fluconazole100%Part D≥17 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force
American Journal of Transplantation
2025 - Crystalline Nephropathy Due to 2,8-Dihydroxyadeninuria in a Transplanted Kidney: 2 Case Reports
American Journal of Case Reports
2025 - Hemophagocytic Lymphohistiocytosis Due to Disseminated Toxoplasmosis in a Kidney Transplant Patient
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”